ReliaTect™ Post-Op Dressing with CHG
ReliaTect™ Post-Op Dressing with CHG provides broad-spectrum antimicrobial effect through proprietary Benehold™ CHG adhesive technology, absorbency for moisture management within a thin, conformable film, and transparency for visualization of the post-op site.
ReliaTect™ Post-Op Dressing with CHG is intended to cover and protect a wound caused by percutaneous medical devices such as drains, chest tubes, orthopedic pins, fixtures, and wires. ReliaTect™ may also be used to cover and secure a primary dressing. ReliaTect™ inhibits microbial growth within the dressing and prevents external contamination.
|Absorptive dressing format||●|
|Alginate dressing format|
|Antimicrobial effects up to 3 days|
|Antimicrobial effects up to 48 hours|
|Antimicrobial effects up to 7 days||●|
|Collagen dressing format|
|Composite dressing format|
|Contact layer dressing format|
|Foam dressing format|
|Gauze or non-woven dressing format|
|Hydrogel (amorphous) dressing format|
|Hydrogel (impregnated) dressing format|
|Hydrogel (sheet) dressing format|
|Impregnated dressing format|
|Moisture vapor permeable||●|
|Secondary dressing required|
|Sustained release formula|
|Transparent film dressing format|
|Wound filler dressing format|
Eloquest Healthcare is the hospital subsidiary of the Ferndale Pharma Group and is focused on delivering solutions that minimize infection risk, increase patient and caregiver satisfaction and lower treatment costs.